Acute gvhd and chronic gvhd. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy24

Antilymphocyte Serum T-Lymphocytes Spleen CD4-Positive T-Lymphocytes Fetal Blood T-Lymphocytes, Regulatory Skin T-Lymphocytes, Helper-Inducer CD8-Positive T-Lymphocytes Hematopoietic Stem Cells B-Lymphocytes T-Lymphocyte Subsets T-Lymphocytes, Cytotoxic Lacrimal Apparatus Dendritic Cells Neutrophils Cells, Cultured Antigen-Presenting Cells Lymphocytes Bone Marrow Cells Bone Marrow Transplants Thymus Gland Killer Cells, Natural

Organisms12

Transplantation Chimera Mice, Inbred DBA Mice, Inbred C57BL Radiation Chimera Mice, Inbred BALB C Chimera Mice, Knockout Mice, Inbred C3H Mice, Inbred Strains Mice, Inbred AKR Mice, SCID Mice, Transgenic

Diseases34

Graft vs Host Disease Hematologic Neoplasms Acute Disease Chronic Disease Anemia, Aplastic Leukemia Recurrence Hematologic Diseases Infection Leukemia, Myelogenous, Chronic, BCR-ABL Positive Myelodysplastic Syndromes Precursor Cell Lymphoblastic Leukemia-Lymphoma Leukemia, Myeloid, Acute Skin Diseases Leukemia, Myeloid Multiple Myeloma Lymphoma Hepatic Veno-Occlusive Disease Intestinal Diseases Severe Combined Immunodeficiency Dry Eye Syndromes Cytomegalovirus Infections Anemia, Refractory, with Excess of Blasts Fanconi Anemia Disease Models, Animal Lymphoma, Non-Hodgkin Disease Progression Neoplasms Thrombotic Microangiopathies Pancytopenia Lymphoproliferative Disorders Leukemia, Myelomonocytic, Acute Leukemia, Experimental Leukemia, Myeloid, Chronic-Phase

Chemicals and Drugs47

Immunosuppressive Agents HLA Antigens Busulfan Vidarabine Antilymphocyte Serum Methotrexate Cyclosporine Myeloablative Agonists Tacrolimus Granulocyte Colony-Stimulating Factor Cyclophosphamide Cyclosporins Melphalan Antigens, CD34 Prednisone Antibodies, Monoclonal Antibodies, Neoplasm Isoantigens Adrenal Cortex Hormones B-Cell Activating Factor Methylprednisolone Minor Histocompatibility Antigens Interferon-gamma Steroids Cytokines Receptors, Interleukin-2 Tumor Necrosis Factor-alpha Antigens, CD Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents Interleukin-10 Antibodies, Monoclonal, Humanized Membrane Glycoproteins Recombinant Proteins Biological Markers Antigens, CD3 HLA-DP beta-Chains Pore Forming Cytotoxic Proteins Ganciclovir Fas Ligand Protein Interleukin-21 Receptor alpha Subunit Interleukin-2 Mycophenolic Acid H-2 Antigens Forkhead Transcription Factors Antigens, CD8 HLA-DP Antigens

Analytical, Diagnostic and Therapeutic Techniques and Equipment60

Transplantation, Homologous Bone Marrow Transplantation Hematopoietic Stem Cell Transplantation Transplantation Conditioning Histocompatibility Testing Photopheresis Peripheral Blood Stem Cell Transplantation Lymphocyte Transfusion Whole-Body Irradiation Lymphocyte Depletion Cord Blood Stem Cell Transplantation Treatment Outcome Leukocyte Transfusion Survival Analysis Disease-Free Survival Retrospective Studies Transplantation, Isogeneic Survival Rate Actuarial Analysis Life Tables Immunosuppression Stem Cell Transplantation Remission Induction Hematopoietic Stem Cell Mobilization Incidence Risk Factors Follow-Up Studies Cause of Death Lymphocyte Count Combined Modality Therapy Prospective Studies Salvage Therapy Multivariate Analysis Transplantation, Autologous Lymphocyte Activation Leukocyte Count Prognosis Lymphocyte Culture Test, Mixed Drug Therapy, Combination Cohort Studies Pilot Projects Severity of Illness Index Antineoplastic Combined Chemotherapy Protocols Risk Disease Models, Animal Immunophenotyping Flow Cytometry Proportional Hazards Models Immunotherapy, Adoptive Registries Adoptive Transfer Graft Enhancement, Immunologic Thymectomy Premedication Cell Separation Lymphatic Irradiation Hemibody Irradiation Blood Grouping and Crossmatching Leukemia, Experimental Fatal Outcome

Psychiatry and Psychology3

Nuclear Family Siblings Sibling Relations

Phenomena and Processes24

Histocompatibility Graft vs Leukemia Effect Graft vs Tumor Effect Graft Survival Graft vs Host Reaction Transplantation Immunology Time Factors Radiation Chimera Graft Rejection Lymphocyte Count Lymphocyte Activation Leukocyte Count Risk Hematopoiesis Cytotoxicity, Immunologic Chimerism Drug Resistance Haplotypes Organ Specificity Host vs Graft Reaction Immune Tolerance Minor Histocompatibility Loci Major Histocompatibility Complex Transplantation Tolerance

Anthropology, Education, Sociology and Social Phenomena4

Nuclear Family Siblings National Institutes of Health (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science7

Consensus Development Conferences, NIH as Topic Survival Rate Life Tables Incidence Cause of Death Registries Fatal Outcome

Named Groups6

Tissue Donors Unrelated Donors Siblings Blood Donors Living Donors Infant, Newborn

Health Care23

Consensus Development Conferences, NIH as Topic Treatment Outcome Survival Analysis Disease-Free Survival Retrospective Studies Survival Rate Actuarial Analysis Life Tables Incidence Risk Factors Follow-Up Studies National Institutes of Health (U.S.)Cause of Death Prospective Studies Multivariate Analysis Cohort Studies Pilot Projects Severity of Illness Index Risk Proportional Hazards Models Age Factors Registries Fatal Outcome

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Graft vs Host Disease Transplantation, Homologous Bone Marrow Transplantation Hematopoietic Stem Cell Transplantation Transplantation Conditioning Histocompatibility Hematologic Neoplasms Acute Disease Tissue Donors Chronic Disease Histocompatibility Testing Consensus Development Conferences, NIH as Topic Anemia, Aplastic Immunosuppressive Agents Graft vs Leukemia Effect Graft vs Tumor Effect Photopheresis Peripheral Blood Stem Cell Transplantation Lymphocyte Transfusion Leukemia Graft Survival Whole-Body Irradiation Lymphocyte Depletion Transplantation Chimera HLA Antigens Nuclear Family Recurrence Busulfan Vidarabine Graft vs Host Reaction Antilymphocyte Serum Unrelated Donors Methotrexate Cyclosporine Cord Blood Stem Cell Transplantation Treatment Outcome Leukocyte Transfusion Survival Analysis Siblings Myeloablative Agonists Hematologic Diseases Disease-Free Survival Retrospective Studies T-Lymphocytes Transplantation, Isogeneic Infection Leukemia, Myelogenous, Chronic, BCR-ABL Positive Tacrolimus Myelodysplastic Syndromes Survival Rate Transplantation Immunology Actuarial Analysis Precursor Cell Lymphoblastic Leukemia-Lymphoma Mice, Inbred DBA Life Tables Immunosuppression Stem Cell Transplantation Granulocyte Colony-Stimulating Factor Cyclophosphamide Mice, Inbred C57BL Remission Induction Leukemia, Myeloid, Acute Hematopoietic Stem Cell Mobilization Cyclosporins Melphalan Spleen Blood Donors Time Factors CD4-Positive T-Lymphocytes Incidence Skin Diseases Risk Factors Antigens, CD34 Living Donors Fetal Blood Radiation Chimera Prednisone Follow-Up Studies Graft Rejection National Institutes of Health (U.S.)Cause of Death Antibodies, Monoclonal Leukemia, Myeloid T-Lymphocytes, Regulatory Antibodies, Neoplasm Lymphocyte Count Isoantigens Multiple Myeloma Combined Modality Therapy Skin Prospective Studies Salvage Therapy Adrenal Cortex Hormones Multivariate Analysis Transplantation, Autologous Mice, Inbred BALB C Lymphocyte Activation T-Lymphocytes, Helper-Inducer Lymphoma CD8-Positive T-Lymphocytes

No FAQ available that match "acute gvhd and chronic gvhd"